The finding of no SOAT1 GWAS SNPs associated with lipoprotein levels, atherosclerotic disease, or Alzheimer’s disease, which have been the objectives of large, well-powered GWAS studies, indicates that the SOAT1 expression levels do not play a significant role in these phenotypes. The gene discussed is SOAT1; the disease is early-onset autosomal dominant Alzheimer disease.